Leap Therapeutics
Presence
Leap Therapeutics is a company listed under the stock ticker LPTX (US).
Executives
Most searched biographies at Leap Therapeutics
- Doug Onsi, President, Chief Executive Officer and Chief Financial ...
- William Li, Director
- Monica Bertagnolli, Director
Create an alert
to follow the executive moves at Leap Therapeutics.
Industry
Leap Therapeutics has 1,797 competitors including Neptune Wellness Solutions (Canada), Eurofins (Luxembourg) and Biogen (United States (USA)).
Popular M&A news in Biotechnology
- Delix Therapeutics has just announced a $70 Millions round of funding. (posted on Sep 28, 2021).
- SmartLabs has just announced a $250 Millions round of funding. (posted on Sep 23, 2021).
- Evommune has just announced a $83 Millions round of funding. (posted on Sep 21, 2021).
Popular contacts in Biotechnology
News
Press releases by Leap Therapeutics
- Leap Therapeutics Announces Closing of Public Offering of Common Stock and Pre-Funded Warrants and Full Exercise of Underwriters' Option to Purchase Additional Shares | Leap Therapeutics, Inc.
- Leap Therapeutics Announces Pricing of $90 million of Common Stock and Pre-Funded Warrants | Leap Therapeutics, Inc.
- Leap Therapeutics Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants | Leap Therapeutics, Inc.
- Leap Therapeutics Presents Updated Positive Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO Congress | Leap Therapeutics, Inc.
- Leap Therapeutics to Present New Data from the DisTinGuish Study of DKN-01 Plus Tislelizumab at the ESMO 2021 Congress | Leap Therapeutics, Inc.
Social media about Leap Therapeutics
- Leap Therapeutics on Wikipedia, Google News & Yahoo Finance
- Leap Therapeutics on LinkedIn, Twitter & YouTube
Get in Touch
Contact by email its executives including Chris Mirabelli 
Call Leap Therapeutics at +1 617...
